Addex Therapeutics Ltd ADR (ADXN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,715 | -11,671 | -7,700 | -4,306 | N/A |
| Depreciation Amortization | 399 | 317 | 200 | 96 | N/A |
| Accounts receivable | 53 | 46 | 15 | 51 | N/A |
| Accounts payable and accrued liabilities | -1,691 | -2,479 | -1,856 | 515 | N/A |
| Other Working Capital | -1,638 | -4,088 | -4,020 | -207 | N/A |
| Other Operating Activity | 3,601 | 3,864 | 2,645 | -310 | 0 |
| Operating Cash Flow | $-12,991 | $-14,010 | $-10,716 | $-4,160 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -63 | -12 | -11 | -9 | N/A |
| Investing Cash Flow | $-63 | $-12 | $-11 | $-9 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Repurchased | 768 | -30 | -41 | -3 | N/A |
| Other Financing Activity | -719 | -452 | -321 | -214 | 0 |
| Financing Cash Flow | $50 | $-482 | $-362 | $-217 | $N/A |
| Exchange Rate Effect | -692 | -417 | -187 | 33 | N/A |
| Beginning Cash Position | 33,637 | 34,290 | 32,726 | 32,609 | N/A |
| End Cash Position | 19,940 | 19,369 | 21,450 | 28,049 | N/A |
| Net Cash Flow | $-13,697 | $-14,921 | $-11,276 | $-4,561 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,991 | -14,010 | -10,716 | -4,160 | N/A |
| Capital Expenditure | -63 | -12 | -11 | -9 | N/A |
| Free Cash Flow | -13,055 | -14,022 | -10,727 | -4,169 | 0 |